Catalyst Wire Dossier Catalyst Wire Dossier

XueZhiKang (XZK)

XZK · Beijing Peking University WBL Biotech Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XueZhiKang (XZK), covering 2014-07-23 to 2014-07-23. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Lipid-Lowering Effects of XueZhiKang (XZK) in Patients With Hyperlipidemia [Phase 2]

See pricing